Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01350336 · ClinicalTrials.gov registry record · NA
Bronchial Thermoplasty in Severe Persistent Asthma
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 284
- Enrollment target
NCT01350336 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 284 participants.
The verdict
NCT01350336, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 284 participants
- Enrollment target
Study Summary
As Conditions of Approval of the PMA for the Alair System, the FDA requires Boston Scientific to generate data to assess the durability of the BT treatment effect as well as safety data in the intended use population in the United States.
Interventions
- DEVICE Alair System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 284 participants |
| Start Date | 2011-04-07 |
| Est. Completion | 2020-03-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01350336
The ClinicalTrials.gov registry entry for NCT01350336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alair System is the first listed.
NCT01350336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01350336 about?
NCT01350336 is a clinical study titled "Bronchial Thermoplasty in Severe Persistent Asthma". As Conditions of Approval of the PMA for the Alair System, the FDA requires Boston Scientific to generate data to assess the durability of the BT treatment effect as well as safety data in the intended use population in the United States.
What is the current status of trial NCT01350336?
This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2011-04-07. Estimated completion is 2020-03-17.
What interventions are being tested in trial NCT01350336?
The interventions under investigation include: Alair System (DEVICE).
Who is sponsoring clinical trial NCT01350336?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.